论文部分内容阅读
自从3年前首次发现后适应能显著减少心肌再灌注损伤,已有大量研究证实后适应在多个种属均有效。在不久前的一个小样本临床试验中,后适应对急性心肌梗死后患者的心脏有着显著保护作用。这个研究使得科研人员和临床医生开始关注后适应在人体中的心脏保护作用及其临床应用价值。
Since it was first discovered 3 years ago that postconditioning can significantly reduce myocardial reperfusion injury, a large number of studies have demonstrated that post-conditioning is effective in multiple species. In a recent small clinical trial, postconditioning had a significant protective effect on the heart of patients after acute myocardial infarction. This study allows researchers and clinicians to begin to focus on cardioprotection in humans and their clinical value.